MedEye Associates

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Diabetic eye disease3 trials
• Macular degeneration3 trials

Phase

• Phase 34 trials
• Phase 11 trial
• Phase 21 trial

Status

• Active, not recruiting5 trials
• Completed1 trial

Lead sponsor

• EyePoint Pharmaceuticals, Inc.3 trials
• Genentech, Inc.1 trial
• Ocular Therapeutix, Inc.1 trial
• Oxurion1 trial

Running trials

• Active, not recruiting

  CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

  NCT07449923· Phase 3· EyePoint Pharmaceuticals, Inc.· Source

• Active, not recruiting

  Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration

  NCT06495918· Phase 3· Ocular Therapeutix, Inc.· Source

• Active, not recruiting

  A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56

  NCT06683742· Phase 3· EyePoint Pharmaceuticals, Inc.· Source

• Active, not recruiting

  A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56

  NCT06668064· Phase 3· EyePoint Pharmaceuticals, Inc.· Source

• Active, not recruiting

  A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME)

  NCT06847854· Phase 1· Genentech, Inc.· Source

Closed trials

• Completed

  A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema

  NCT04527107· Phase 2· Oxurion· Source